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IntroductIon
Vaccinia-related kinases (VRKs) belong to the casein kinase 
family, whose catalytic domain shares sequence homology 
with the vaccinia virus gene B1R. VRKs are multifaceted 
serine/threonine kinases that play essential roles in many 
aspects of cell signaling, cell cycle progression, nuclear en-
velope dynamics, histone modification, and apoptosis (Kang 
and Kim, 2006; Klerkx et al., 2009; Park et al., 2015). Abnor-
mal VRK functions result in various diseases. Dysregulation 
of VRK1 and VRK2 is reported to cause spinal muscular 
atrophies and schizophrenia, respectively (Renbaum et al., 
2009; Sohn et al., 2014).
VRK3, one of the VRK subtypes, is highly expressed 
during development and promotes cell cycle progression by 
phosphorylating the nuclear envelope protein BAF (barrier 
to autointegration factor; Park et al., 2015). VRK3 decreases 
extracellular signal-regulated kinase (ERK) activity through 
direct binding to a mitogen-activated protein kinase phos-
phatase, vaccinia H1-related, which specifically inactivates 
ERK in the nucleus (Kang and Kim, 2006). ERKs are hub 
kinases that activate various signaling pathways in many types 
of cells, including neurons (Flavell and Greenberg, 2008). 
Neuronal ERK signaling is involved in the regulation of syn-
aptic protein synthesis, dendritic morphology, and functional 
plasticity (Wu et al., 2001; Thomas and Huganir, 2004; Kelle-
her and Bear, 2008). Dysregulation of ERK signaling can re-
sult in autism spectrum disorder (ASD; Faridar et al., 2014; 
Subramanian et al., 2015; Yufune et al., 2015). Notably, de-
letion or duplication of chromosomal locus 16p11.2, which 
includes the ERK1 gene, is commonly associated with ASD 
(Qureshi et al., 2014).
As a modulator of ERK signaling, VRK3 is also thought 
to play a critical role in neuronal function. Amyloid-β oligo-
mers induce a down-regulation of VRK3, which could 
contribute to synaptic dysfunction in Alzheimer’s disease 
(Sebollela et al., 2012). Interestingly, copy-number variants 
(CNVs) at the 19q13.33 region, which includes the VRK3 
gene (NM_016440), are associated with ASD and other intel-
lectual disabilities (Firth et al., 2009; Xu et al., 2012). However, 
the synaptic function of VRK3 is still unknown, although the 
role of VRK3 in synaptic structure and function is critical to 
understand the etiology of ASD caused by VRK3 mutations.
In this study, by generating VRK3-deleted mice with 
a reporter in the VRK3 intron region, we explored whether 
VRK3 deletion causes symptoms similar to those of psychi-
atric disorders in humans and investigated the mechanisms 
underlying this effect. We found that VRK3-knockout 
(VRK3-KO) mice exhibited autism-like behaviors as well as 
altered synaptic structure and function. Also, we found that 
Vaccinia-related kinases (VrKs) are multifaceted serine/threonine kinases that play essential roles in various aspects of cell 
signaling, cell cycle progression, apoptosis, and neuronal development and differentiation. However, the neuronal function of 
VrK3 is still unknown despite its etiological potential in human autism spectrum disorder (ASd). Here, we report that VrK3-de-
ficient mice exhibit typical symptoms of autism-like behavior, including hyperactivity, stereotyped behaviors, reduced social 
interaction, and impaired context-dependent spatial memory. A significant decrease in dendritic spine number and arborization 
were identified in the hippocampus cA1 of VrK3-deficient mice. these mice also exhibited a reduced rectification of AMPA 
receptor–mediated current and changes in expression of synaptic and signaling proteins, including tyrosine receptor kinase B 
(trkB), Arc, and caMKIIα. notably, trkB stimulation with 7,8-dihydroxyflavone reversed the altered synaptic structure and 
function and successfully restored autism-like behavior in VrK3-deficient mice. these results reveal that VrK3 plays a critical 
role in neurodevelopmental disorders and suggest a potential therapeutic strategy for ASd.
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activation of the tyrosine receptor kinase B (TrkB) signaling 
pathway alleviated these abnormalities in VRK3-KO animals.
reSultS
VrK3-Ko mice exhibit autism-like behavior
In the present study, we generated VRK3-depleted mice 
(Fig. S1 A). The deletion mutation between exons 7 and 8 
was verified using various PCR methods (Fig. 1, A and B). 
Loss of full-length VRK3 protein was verified by Western 
blot (Fig. 1 C). The gene trap insertion sites on VRK3 pro-
tein are shown in Fig. S1 B. We first sought to determine 
whether VRK3-KO mice displayed unusual social interac-
tions and repetitive behaviors, which are core symptoms of 
ASD. Both VRK3-KO and WT mice had no preference for 
the right and the left chambers during a habituation period 
(Fig. 1 D). However, VRK3-KO mice did not show any pref-
erence for exploring a novel mouse-containing cage over a 
novel empty cage in a three-chamber test (Fig. 1 E). When a 
novel mouse was placed in the empty cage to assess discrim-
ination between new and familiar mice, VRK3-KO mice 
showed no significant preference for exploring the novel 
mouse (Fig.  1  F). VRK3-KO mice exhibited longer dura-
tions of grooming behavior (Fig. 1 G). To explore maternal 
care on pup behavior, we measured latency for pup retrieval 
from a scattered nest and found that VRK3-KO female mice 
retrieved pups less efficiently than WT mice (Fig. 1 H). In 
addition, VRK3-KO mice also performed less efficiently than 
WT mice in a nesting behavior assay (Fig. 1 I). These results 
suggest that VRK3-KO mice display unusual social interac-
tions and autism-related behavioral abnormalities.
decreased VrK3 weakened hippocampus-dependent 
cognitive functions, including spatial learning and memory
We next analyzed other cognitive defects in VRK3-KO ani-
mals. VRK3-KO mice showed shorter step-through latencies 
than WT mice after experiencing electric shock in a dark 
room (Fig. 2 A). In a novel object recognition test, VRK3-KO 
mice exhibited a reduced ability to discriminate between fa-
miliar and novel objects at 24 h after training (Fig. 2 B). The 
Barnes circular maze test also showed that VRK3-KO mice 
had significantly impaired spatial memory compared with 
WT mice without a change in exploratory behavior after 4 d 
of training (Fig. 2 C). In an open-field test, VRK3-KO mice 
displayed hyperactivity and anxiolytic behavior (Fig.  2  D), 
which were confirmed by the results obtained from elevated 
plus maze (EPM) and light–dark exploration test, yet the dis-
tance moved in the EPM remained normal (Fig.  2, E and 
F). These data suggest that VRK3-KO mice have impaired 
cognitive functions, including spatial learning and memory as 
well as anxiolytic behavior. In addition, VRK3-heterozygous 
mice exhibited anxiolytic behavior and hyperactivity (Fig. 
S2, A and B) along with reduced performance in novel ob-
ject recognition test (Fig. S2 C). VRK3-heterozygous mice 
also revealed impaired learning and memory performance in 
Barnes circular maze test (Fig. S2 D).
VrK3-Ko mice show decreased spine number and 
arborization as well as abnormal PSd
Next, we examined the morphology of dendritic spines in 
the hippocampus (Fig.  3, A and F). VRK3-KO mice ex-
hibited significant reductions in spine density in the CA1 
(Fig. 3 B) and dentate gyrus (DG) regions (Fig. 3 G). In the 
CA1 region, reductions in spine density were more promi-
nent on basal dendrites than apical dendrites in VRK3-KO 
animals (Fig. 3 B). Interestingly, the length of dendritic spines 
was markedly increased in all spine types of the CA1 region 
(Fig. 3 C), whereas it was not changed in the DG region of 
VRK3-KO animals (Fig. 3 I). We found similar proportions 
of all types of dendritic spines in the CA1 and DG regions 
between WT and VRK3-KO mice (Fig. 3, E and J). We fur-
ther analyzed postsynaptic density (PSD) in hippocampal 
CA1 regions using electron microscopy (Fig. 3 K), which re-
vealed prominent reductions in PSD length and thickness in 
VRK3-KO mice (Fig. 3, L and M). We also found decreased 
dendritic arborization in VRK3-KO animals with Sholl anal-
ysis (Fig. 3, N and O). These results suggest alterations in den-
dritic spines and concomitant decreases of PSD structure in 
hippocampus of VRK3-KO animals.
VrK3-Ko mice show a decreased proportion of 
ca2+-permeable AMPA receptors
We characterized the synaptic transmission and plasticity in 
VRK3-KO mice. The amplitude and frequency of miniature 
excitatory postsynaptic currents (mEPSCs; Fig.  4 A), min-
iature inhibitory postsynaptic currents (mIPSCs; Fig.  4 B), 
spontaneous excitatory postsynaptic currents (sEPSCs; Fig. 
S3 A) and spontaneous inhibitory postsynaptic currents 
(sIPSCs; Fig. S3 B) were identical in WT and VRK3-KO 
mice in pyramidal cells of the hippocampal CA1 region. 
The input–output relationship for the CA3–CA1 Schaffer 
collateral (SC) circuit of VRK3-KO mice was also normal 
(Fig. S3 C). Theta-burst stimulation induced NMDA recep-
tor–dependent long-term potentiation (LTP; Fig. 4 C) was 
also normal in in VRK3-KO mice. We tested two types of 
long-term depression (LTD) induction: single-pulse stimu-
lation induced NMDA receptor–dependent LTD and DH-
PG-induced metabotropic glutamate receptor–dependent 
LTD. However, both forms of LTD are intact in VRK3-KO 
mice (Fig. 4 D and Fig. S3 D). Moreover, VRK3-KO mice 
showed normal intrinsic excitability of hippocampal CA1 
pyramidal cells (Fig. 4 E), paired-pulse ratio (Fig. 4 F), and 
20-Hz-train stimulation-mediated excitatory postsynaptic 
current (EPSC) response (Fig. 4 H), implying intact presyn-
aptic neurotransmitter release in VRK3-KO animals. The 
ratio between AMPA and NMDA receptor activity was the 
same in WT and VRK3-KO mice (Fig. 4 G). Notably, how-
ever, the ratio of AMPA receptor–mediated currents mea-
sured at 40 and −70 mV holding potentials (also known as 
rectification) was decreased in VRK3-KO mice (Fig.  4, I 
and J), suggesting a decreased proportion of Ca2+-permeable 
AMPA receptor in VRK3-KO mice.
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Figure 1. VrK3-Ko mice exhibit autism-like behavior. (A) Genotypes of VRK3-knockout (VRK3-KO) mice were determined by PCR of tail DNA, and 
verification of VRK3-KO mice, which contain a gene encoding β–galactosidase, was performed by Western blot analysis. (B) VRK3 mRNA level was quantified 
by real-time RT-PCR. VRK3 mRNA level was normalized to Rpl32 mRNA level (n = 7, 7 for WT and VRK3-KO mice, respectively; t12 = 27.45, ***, P < 0.001, t 
test). (C) Western blot probed with an antibody directed against VRK3. Full-length VRK3 protein is absent in VRK3-KO mice. (D) The preference for either side 
of the three-chamber unit in the habituation period (n = 5, 5), and time spent (top) and number of entries (bottom) for the left (blank bar) and right chamber 
(filled bar) of the three-chamber unit. (E) Sociability (mouse 1 [blank bar] versus object [filled bar]) in a three-chamber assay, time spent investigating (left; 
n = 5, 5; interaction F1,8 = 5.37, two-way ANO VA; **, P < 0.01, P > 0.05, Bonferroni’s post-test), total number of entries (middle; n = 11, 13; interaction F1,44 
= 10.81, P = 0.002, two-way ANO VA; *, P < 0.05, P > 0.05, Bonferroni’s post-test), and time spent in each chamber (right; n = 11, 13; WT vs. VRK3 KO F1,44 
= 18.36, P < 0.0001, interaction F1,44 = 14.25, P = 0.0005, two-way ANO VA; ***, P < 0.001, P > 0.05, Bonferroni’s post-test). (F) Preference for social novelty 
(familiar mouse [blank bar] vs. novel mouse [filled bar] in a three-chamber assay, time spent investigating (left; n = 5, 5; WT vs. VRK3 KO F1,8 = 7.68, *, P < 
0.05, interaction F1,8 = 5.82, *, P < 0.05, two-way ANO VA; **, P < 0.01, P > 0.05, Bonferroni’s post-test), total number of entries (middle; n = 11, 13; WT vs. 
VRK3 KO F1,44 = 9.50; **, P < 0.01; two-way ANO VA; *, P < 0.05, P > 0.05, Bonferroni’s post-test), and time spent in each chamber (right; n = 11, 13; WT vs. 
VRK3 KO F1,44 = 13.00, P = 0.0008, two-way ANO VA; **, P < 0.01, P > 0.05, Bonferroni’s post-test). (G) Duration of repetitive behavior in a grooming task (n 
= 11, 13; t22 = 5.369, ***, P < 0.001, t test). (H) Latency to pup retrieval (n = 6, 7; WT vs. VRK3-KO female mice F2,33 = 18.35, P < 0.0001, two-way ANO VA; 
*, P < 0.05, Bonferroni’s post-test). (I) Nest-building index over 3 d of a nesting behavior test (n = 6, 7; WT vs. VRK3 KO F2,33 = 15.72, P < 0.0001, two-way 
ANO VA; *, P < 0.05, Bonferroni’s post-test). n.s., not significant. All values represent mean ± SEM.
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VrK3 deletion causes alteration of 
synaptic protein expression
We next examined the synaptic scaffolds and signaling adap-
tors/proteins. Among signaling proteins, VRK3-KO mice 
exhibited a marked increase in CaMKIIα and ERK phos-
phorylation, whereas mTOR and S6K phosphorylation 
marginally decreased (Fig.  5  A). Among scaffold proteins, 
there were no differences in the expression levels of Homer1, 
synaptic GTPase-activating protein (SynGAP), and SAP97 
between WT and VRK3-KO mice. However, levels of Arc 
(Sala et al., 2003) were increased, whereas levels of other syn-
aptic proteins, including syntaxin, PAK3, and PSD-95 (Jurado 
et al., 2013), were reduced (Fig. 5 B). Among the receptor 
proteins, there were no differences in the expression levels 
of glutamate receptors (such as mGluR1, GluA2, GluA3, 
GluN2A, and GluN2B) between WT and VRK3-KO 
mice (Fig.  5  C). Interestingly, GluN1 expression was ele-
vated, whereas TrkB expression was reduced (Fig. 5 C). We 
further quantified synaptic proteins by separating the syn-
aptosomal PSD fraction. In the total lysate, we found that 
levels of GluA1, PSD95, and phosphorylated TrkB were de-
creased. However, the decrease in the GluA1 expression was 
very subtle, whereas the decrease in levels of both PSD95 
and phosphorylated TrkB was obvious in the PSD fraction 
Figure 2. VrK3-Ko mice exhibit impaired learning and memory and abnormal behavior. (A) Passive avoidance. Step-through latencies into the 
dark compartment before (untrained) and 2 d after foot shock (test; n = 14, 15 for WT and VRK3-KO mice, respectively; WT vs. VRK3 KO F1,54 = 115.63, P < 
0.0001, untrained vs. test F1,54 = 88.63, P < 0.0001; interaction F1,54 = 82.15, P < 0.0001, two-way ANO VA; P > 0.05, ***, P < 0.001, Bonferroni’s post-test). 
(B) The novel object recognition test with discrimination index for a familiar objects (left; F1, familiar 1; F2, familiar 2), which was presented 24 h before the 
test (n = 5, 5; P > 0.05, t test), and discrimination index for novel object recognition ability (right; n = 5, 5; *, P < 0.05, t test). (C) Barnes circular maze with 
number of errors across each day of training (left; n = 15, 15; trial sessions F1,110 = 4.35, P < 0.05; genotype F3,110 = 32.30, P < 0.0001, two-way ANO VA; P 
> 0.05, Bonferroni’s post-test). Probe test on the fifth and 12th day of training with correct pokes (middle left; n = 14, 14 for WT and VRK3-KO mice; day 
5 vs. day 12, F1,45 = 7.90, P < 0.01; WT vs. VRK3 KO, F1,45 = 13.44, P < 0.001, two-way ANO VA; *, P < 0.05; **, P < 0.01; ***, P < 0.001, Bonferroni’s post-test), 
and time in target (middle right; n = 14, 14; day 5 vs. day 12, F1,45 = 11.45, P < 0.01; WT vs VRK3 KO, F1,45 = 26.46, P < 0.0001, two-way ANO VA; **, P < 0.01, 
Bonferroni’s post-test), and distance moved (right; n = 14, 14; P > 0.05, t test). (D) Total locomotor activity (left) and time spent in the center region (right) 
of the open field (n = 11, 14; **, P < 0.01, t test). (E) Time spent in open arms (left) and total locomotor activity (right) in the elevated plus maze (n = 12, 12; 
**, P < 0.01, P > 0.05, t test). (F) Duration of time spent in the light compartment in the light-dark exploration test (n = 12, 14; ***, P < 0.001, t test). n.s., not 
significant. All values represent mean ± SEM.
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(Fig. 5 D). Also, levels of Arc and phosphorylated CaMKIIα 
were increased in the PSD fraction (Fig. 5 D). We analyzed 
and compared the PSD fractions in VRK3-KO mice at ages 
4 and 12 wk but observed no difference in expression pat-
terns between the two groups (Fig. S4). The quantitative 
ratio of AMPA receptor and NMDA receptor in the PSD 
fraction was identical in WT and VRK3-KO mice (Fig. S4). 
These data suggest the possibility that expression of the cy-
toskeleton, scaffolding proteins, and core signaling factors is 
largely changed in synapses of VRK3-KO mice.
treatment with a trkB agonist restores a normal 
expression pattern of the synaptic and signaling proteins 
altered in VrK3-Ko mice
Having observed changes in molecular components in 
VRK3-KO mice, we next sought to examine whether res-
toration of ERK activity can correct the altered expression 
profile of synaptic proteins. We therefore tested the effect of 
7,8-dihydroxyflavone (7,8-DHF), a selective and blood–brain 
barrier–permeable TrkB agonist, on protein expression in 
VRK3-KO mice. Multiple studies describe the restorable ef-
Figure 3. Alteration of synaptic structures in cA1 and dG regions of VrK3-Ko mice. (A) Representative images of dendrites in CA1 pyramidal 
neurons of WT and VRK3-KO mice. Bars, 10 µm. (B) Quantification of spine density (spines per 10 µm) on apical and/or basal dendrites in the CA1 region 
(n = 44, 114 dendrites from 6, 8 mice of WT and VRK3-KO mice, respectively; **, P < 0.01, t test). (C) Quantification of spine length on apical and/or basal 
dendrites in the CA1 region (n = 665, 1,621 spines from 6, 8 mice; ***, P < 0.001; **, P < 0.01, t test). (D) Dendritic spines in the CA1 region were classified 
as thin, stubby, mushroom, or branched. Spine length for specific spine subtypes in the CA1 region (n = 88–574 spines from 6, 8 mice; ***, P < 0.001; *, P < 
0.05, t test). (E) Comparable proportions of each type of spine on apical and basal dendrites in the CA1 region of WT and VRK3-KO mice (n = 6, 8 mice; P 
> 0.05, χ2 test). (F) Representative images of dendrites in the DG region of WT and VRK3-KO mice. Bars, 10 µm. (G) Quantification of spine density (spines 
per 10 µm) in the DG region (n = 37, 40 dendrites from four mice per genotype; t75 = 2.326, *, P < 0.05, t test). (H) Quantification of spine length in the DG 
region (P > 0.05, t test). (I) Spine length for specific spine subtypes in the DG region (P > 0.05, t test). (J) Comparable proportions of each type of spine in the 
DG region of WT and VRK3-KO mice (n = 4, 4 mice; P > 0.05, χ2 test). (K) Representative electron micrographs of hippocampal CA1 synapses showing the 
presence (magnification 120,000×) of PSD (arrows), synaptic vesicles (arrowheads), and dendritic spines (asterisks). Bars, 200 nm. (L) PSD length (n = 214, 
321 synapses from 3, 3 mice; ***, P < 0.001, t test). (M) PSD thickness (n = 155, 236 synapses from 3, 3 mice; ***, P < 0.001, t test). (N) Reconstructions of 
representative neurons of Golgi-stained pyramidal neurons. Bar, 50 µm. (O) Number of intersections of the dendrite at different distances (radius) from the 
soma (center of analysis) from Sholl analysis (n = 5 neurons). A repeated-measures ANO VA indicates a statistical significance for genotype (F1,56 = 5.63, P = 
0.02; *, P < 0.05), but not radius (distance) genotype, interaction (F1,56 = 0.61, P = 0.84). n.s., not significant. All values represent mean ± SEM.
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fect of 7,8-DHF on synaptic plasticity in a variety of animal 
models of neurological disorders, including models of Rett’s 
syndrome and fragile X syndrome (Johnson et al., 2012; Tian et 
al., 2015). First, we confirmed repeatedly that the phosphory-
lated-ERK/ERK ratio is increased in VRK3-KO mice (Fig. 6, 
A and B). Also, we confirmed that the expression level of 
TrkB was low in VRK3-KO animals (Fig. 6 D). Notably, ERK 
phosphorylation in WT animals was rapidly increased at 1 h of 
7,8-DHF treatment and then returned to base levels, whereas 
ERK phosphorylation in VRK3-KO animals increased in a 
much slower and delayed manner (Fig. 6 B). Furthermore, an 
elevated Arc expression in VRK3-KO mice returned to a level 
similar to that in WT mice at 2 h after 7,8-DHF treatment 
(Fig. 6, A and C). Also, the decreased levels of phosphorylated 
Figure 4. Altered synaptic transmission in VrK3-Ko mice. (A and B) Representative traces, mean amplitude, and frequency of mEPSCs (A; n = 17, 14 
neurons from 3, 3 mice of WT and VRK3-KO mice, respectively; P > 0.05, t test), and mIPSCs (B; n = 13, 14 neurons from 2, 2 mice; P > 0.05, t test). Bars, 10 
pA, 1 s. (C and D) Theta-burst stimulation (TBS)–induced LTP (C; n = 12, 13 slices from 4, 4 mice; P > 0.05, t test.), and single-pulse low-frequency stimulation 
(SP-LFS)–induced LTD (D; n = 10, 7 slices from 4, 4 mice; P > 0.05, t test) in hippocampal SC-CA1 synapses. Traces were taken 1 min before TBS or SP-LFS 
(gray, light red) and at the end of the recording period (black, red). Bars, 0.5 mV, 10 ms. (E) Intrinsic excitability measured as firing rates against injected 
current (n = 21, 22 neurons from 3, 3 mice; P > 0.05, t test) Bars, 20 mV, 0.2 s. (F) Mean paired-pulse ratio (50-ms interstimulus interval) at SC-CA1 synapses 
(n = 9, 21 neurons from 3, 4 mice; t28 = 0.289, P > 0.05, t test). Bars, 200 pA, 50 ms. (G) AMPA/NMDA receptor activity ratio (n = 15, 18 neurons from 4, 4 
mice; P > 0.05, t test). Bars, 100 pA, 10 ms. (H) 20-Hz stimulation-induced response of hippocampal SC-CA1 synapses (n = 19, 15 neurons from 2, 2 mice; 
P > 0.05, t test). Bars, 100 pA, 0.2 s. (I) Current-voltage relationship of AMPA receptor/EPSCs after paired conditioning at Vh = −70, −60, −40, −20, 0, 20, 
and 40 mV (n = 15, 18 neurons from 4, 4 mice; **, P < 0.01, t test). Bars, 100 pA, 0.2 s. (J) The ratio of AMPA receptor/EPSC amplitudes at +40 mV and −70 
mV holding is depicted (**, P < 0.01, t test). n.s., not significant. All values represent mean ± SEM.
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TrkB (Fig. 6 D), PSD-95 (Fig. 6 E), phosphorylated mTOR 
(Fig. 6 F), and phosphorylated S6K (Fig. 6 G) in VRK3-KO 
mice returned to WT levels after 7,8-DHF treatment. These 
results suggest that aberrant ERK activity induced by VRK3 
deletion caused a marked dysregulation of expression of many 
synaptic signaling proteins in VRK3-KO mice, and a TrkB 
agonist successfully restored the normal expression profile.
trkB stimulation recovers altered synaptic structure and 
function and protein profiles in VrK3-Ko mice
We reasoned that exogenous application of 7,8-DHF could 
reverse the abnormal synaptic structure and function and pro-
tein profiles of VRK3-KO mice. To test the idea, we mon-
itored the effect of 7,8-DHF on synaptic proteins in PSD 
fractions. Notably, we found that the altered expression of 
PSD95, phosphorylated TrkB, and GluA1 and GluN1 re-
turned to normal expression level after 7,8-DHF treat-
ment (Fig.  7 A). However, the increased expression of Arc 
and phosphorylated CaMKIIα in the PSD fraction was not 
changed by 7,8-DHF treatment (Fig.  7  A). We also found 
that bath-applied 7,8-DHF successfully reversed the de-
creased rectification of AMPA receptor–mediated currents 
in hippocampal slices of VRK3-KO mice, whereas 7,8-DHF 
did not affect AMPA receptor responses in hippocampal slices 
of WT mice (Fig. 7 B). Finally, we observed that 7,8-DHF 
restored the reduced number of spines in VRK3-KO ani-
mals (Fig.  7  C). In particular, 7,8-DHF by itself did not 
change the number of spines in the apical region of WT 
animals, implying that 7,8-DHF only suppressed changes 
caused by VRK3 deficiency.
Acute and chronic trkB stimulation substantially 
ameliorates social interaction deficits, but not 
anxiety, in VrK3-Ko mice
Finally, we monitored whether 7,8-DHF improves cognitive 
deficits and autism-like behaviors in VRK3-KO mice. To 
Figure 5. Biochemical changes in the hippocampal PSd fraction and whole lysates of VrK3-Ko mice. (A) CaMKIIα, ERK1/2 (p42/44), mTOR, and 
S6K proteins. The level of phosphoproteins was normalized by KO/WT ratios of total proteins (n = 5–7 for WT and VRK3-KO mice; **, P < 0.01; *, P < 0.05, t 
test). (B) Levels of syntaxin, SynGAP, Homer1, PAK3, Arc, SAP97, and PSD-95; all proteins were normalized by α-tubulin or/and 14-3-3ζ (n = 5–7 for WT and 
VRK3-KO mice; **, P < 0.01; *, P < 0.05, t test). (C) Levels of mGluR1, GluN1, GluN2A, GluN2B, GluA1, GluA2, GluA3, and TrkB; all proteins were normalized by 
α-tubulin or/and 14-3-3ζ (n = 5–7 for WT and VRK3-KO mice; *, P < 0.05, t test). The same 14-3-3ζ loading control was used in both B and C, being the same 
test group. (D) Immunoblot analyses of PSD fractions and whole lysates from 12–13-wk old WT and VRK3-KO mice for the indicated proteins (left). Protein 
levels of GluA1, GluN1, PSD-95, phosphorylated TrkB, phosphorylated CaMKIIα, and Arc in the hippocampal whole lysates (middle) and PSD fractions (right) 
from VRK3-KO mice (n = 6 mice per genotype; ***, P < 0.001; **, P < 0.01; *, P < 0.05, t test). β-Actin was used as a loading control, and all values were nor-
malized to the mean level of the respective protein in the PSD fractions or whole lysates from WT mice. n.s., not significant. All values represent mean ± SEM.
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avoid the possibility of different temporal patterns elicited by 
the pharmacokinetics of TrkB activation (Ji et al., 2010), we 
applied acute and chronic modes of 7,8-DHF delivery to the 
mice. To monitor the acute effect of 7,8-DHF, mice were sub-
jected to behavioral tests at 24 h after three consecutive treat-
ments with 7,8-DHF administered once a day (Fig. 8). In the 
three-chamber test, 7,8-DHF treatment markedly recovered 
the impaired social interaction of VRK3-KO mice compared 
with DMSO treatment (Fig. 8, A and B), but the effect was 
diminished 7 d after treatment (Fig. 8, C and D). We then 
challenged mice with chronic treatment of 7,8-DHF (from 
age 4 wk to 11 wk, for a total of 8 wk; Fig. 9). We found that 
chronic application of 7,8-DHF successfully suppressed the 
increase in grooming activity (Fig.  9 A) and improved ab-
normal social activity (Fig. 9, B and C) in VRK3-KO mice. 
Surprisingly, the beneficial effect of 7,8-DHF on social in-
teraction in VRK3-KO mice was observed 5 wk after the 
last injection (Fig. 9 D). The effect of 7,8-DHF on social ap-
proach behavior, except for social novelty (Fig. 9, E and G), 
persisted for up to 13 wk after the last treatment (Fig. 9 F). 
Finally, we tested the effect of 7,8-DHF on other cogni-
tive changes in VRK3-KO mice. We found that acute 3-d 
consecutive treatments of 7,8-DHF failed to alleviate anxi-
ety behavior in the open field test and EPM (Fig. 10, A and 
B). Even chronic 7,8-DHF treatment did not affect the in-
crease in anxiety behavior of VRK3-KO mice (Fig. 10, C–F). 
However, in both a passive avoidance test and a novel object 
recognition test, chronic treatment with 7,8-DHF success-
Figure 6. trkB stimulation restores dysregulated Arc-induced synaptic plasticity in VrK3-Ko mice. (A–C) Representative Western blots (A) and 
quantitative plots of the time courses of 7,8-DHF–induced ERK (B) and Arc expression (C). Arc protein was normalized by 14-3-3ζ (B: n = 4/4/4/4/4 and n = 
4/4/4/4/4 for vehicle/7,8-DHF(1hr)/7,8-DHF(2hr)/7,8-DHF(4hr)/7,8-DHF(8hr)-treated WT and VRK3-KO mice, respectively; *, P < 0.05, t test; C: n = 4/4/4/4/4 
for WT and n = 4/4/4/4/4 for KO; **, P < 0.01; *, P < 0.05, t test; vehicle-treated VRK3 KO vs. 7,8-DHF [8 h]–treated VRK3 KO; **, P < 0.01, t test). (D–G) Rep-
resentative Western blots and quantitative plots of the time course of 7,8-DHF–induced TrkB (D), PSD-95 (E), mTOR (F), and S6K (G) activation in VRK3-KO 
mice compared with vehicle-treated WT mice (D: n = 5/5/5/5/5 for WT and n = 5/5/5/5/5 for KO; WT vs. VRK3 KO; t8 = 2.577; *, P < 0.05, t test; vehicle-treated 
VRK3 KO vs. 7,8-DHF [2 h]–treated VRK3 KO t8 = 2.325; *, P < 0.05; E: n = 4/4/4/4/4 for WT and n = 4/4/4/4/4 for KO; P > 0.05, t test; vehicle-treated VRK3 
KO vs. 7,8-DHF [2 h]–treated VRK3 KO; *, P < 0.05, t test; F: n = 4/4/4/4/4 for WT and n = 4/4/4/4/4 for KO; P = 0.11; **, P < 0.01; *, P < 0.05, t test; G: n = 
4/4/4/4/4 for WT and n = 4/4/4/4/4 for KO; t6 = 1.538, P = 0.17, t test; vehicle-treated VRK3 KO vs. 7,8-DHF [4 h]–treated VRK3 KO; *, P < 0.05, t test). Each 
densitometry analysis of Western blots in KO mice was normalized by calculation of relative protein levels compared with corresponding values of the 
vehicle-treated (1 h) and 7,8-DHF–treated (1, 2, 4, and 8 h) WT control group after normalization to 14-3-3ζ levels. The same 14-3-3ζ loading control was 
used in both D and E, being the same test group. All values represent mean ± SEM.
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fully reduced the impairment of learning and/or memory in 
VRK3-KO mice (Fig. S5, A and B). These results clearly show 
that 7,8-DHF treatment ameliorates not only the impaired 
social interaction but also stereotyped behaviors and impaired 
learning and memory in VRK3-KO mice and thus support 
the hypothesis that TrkB stimulation could affect autism-like 
behaviors in VRK3-deficient mice.
dIScuSSIon
In this study, we report that VRK3-KO mice exhibited the 
typical symptoms of ASD. VRK3-KO animals also showed 
abnormal synaptic structure and function. These mice showed 
an altered expression pattern of synaptic and signaling pro-
teins such as aberrant ERK, Arc, and CaMKIIα. Ultimately, we 
found that long-term stimulation of TrkB by 7,8-DHF treat-
ment markedly reversed autism-like behavior in VRK3-KO 
mice. Thus, we provide compelling evidence that VRK3 plays 
essential roles in synaptic structure and function, which even-
tually modulate a series of cognitive functions. In addition, 
our results strongly suggest that VRK3-KO mice represent 
an animal model of ASD and that TrkB activation can be a 
possible therapeutic approach to VRK3-related ASD.
A recent study suggests that de novo CNVs are predom-
inant causes of ASD, although the genetic etiology of ∼70% 
of forms of ASD is unknown (Ebert and Greenberg, 2013). 
From the DEC IPH ER database and AutismKB database, we 
identified CNVs encompassing 19:50086504-52125032 (in-
terval 2.04Mb) and 19:54013696-55502526 (AutismKB da-
tabase–reported CNV ID AutCNV0000648), respectively, at 
the 19q13.33 region, which includes the VRK3 gene, that are 
associated with ASD and intellectual disability (DEC IPH ER- 
reported patient ID 251777; Firth et al., 2009; Xu et al., 2012). 
Haploinsufficiency, wherein a single functional copy of a gene 
is insufficient to maintain normal function, is a major cause 
Figure 7. Improvement of the synaptic changes in VrK3-Ko mice by trkB stimulation. (A) Immunoblot analyses of PSD fractions and whole lysates 
from mice at 12 wk after final chronic treatment with 7,8-DHF. Protein levels of GluA1, GluN1, PSD-95, phosphorylated TrkB, phosphorylated CaMKIIα, and 
Arc in the hippocampal whole lysates and PSD fractions (n = 6 mice per genotype; *, P < 0.05, t test). β-Actin was used as a loading control, and all values 
were normalized to the mean level of the respective protein in the PSD fractions or whole lysates from WT mice. (B) Current–voltage relationship of AMPA 
receptor/EPSCs after paired conditioning at Vh = −70, −60, −40, −20, 0, 20, and 40 mV (middle), and rectification index (right) with or without 7,8-DHF 
treatment. Bars, 100 pA, 0.2 s. The ratio of AMPA receptor/EPSC amplitudes at +40 mV and −70 mV holding is also depicted (n = 12 neurons from 3 mice 
for WT_vehicle; n = 13, 3 for VRK3 KO_vehicle; n = 15, 3 for WT_7,8-DHF; n = 14, 2 for VRK3 KO_7,8-DHF; **, P < 0.01 and *, P < 0.05 for WT_vehicle vs. 
VRK3 KO_vehicle; #, P < 0.05 for VRK3 KO_vehicle vs. VRK3 KO_7,8-DHF, two-way ANO VA with Horm–Sidak’s post-test). (C) Quantification of spine density 
(spines per 10 µm) on apical (AC) and/or basal (BS) dendrites in the CA1 region (n = 3 mice per genotype; ***, P < 0.001, t test). n.s., not significant. All 
values represent mean ± SEM.
Autism-like behavior in VRK3-knockout mice | Kang et al.2956
of developmental diseases (Huang et al., 2010). Hence, taking 
into account that 78.63% and 88.9% of haploinsufficiency 
reported in the DEC IPH ER database and UCSC Genome 
Browser, respectively, are expected mutations or deletions of 
VRK3, we can surmise that VRK3 deletion may also con-
stitute one cause of ASD. We found that VRK3-KO animals 
show a series of cognitive impairments that are frequently 
monitored in human ASD patients. VRK3-KO animals dis-
played autism-like behaviors, including hyperactivity, stereo-
typed behaviors, and reduced social interaction, as well as 
impaired context-dependent spatial memory. We also found 
that VRK3-heterozygote mice exhibit behaviors similar to 
those of VRK3-KO animals. These findings support a model 
in which VRK3 gene haploinsufficiency leads to aberrations 
in neuronal functioning, resulting in impaired cognitive and 
behavioral abnormalities.
Because synaptic dysfunction is an important patholog-
ical mechanism in ASD (Delorme et al., 2013; Sztainberg and 
Zoghbi, 2016), we further characterized the synaptopathy in 
VRK3-KO animals. The structural stability of synaptic spine 
is very important for neuronal functions (Lin and Koleske, 
2010; Caroni et al., 2012) and is one pathological mecha-
nism in ASD (Hullinger et al., 2016; Lin et al., 2016). Our 
results show structural defects of VRK3-KO mice, along 
with a decrease in spine number (Fig.  3  B) and dendritic 
arborization (Fig. 3 O). Electronic microscopy results clearly 
showed a decreased length and thickness of the PSD struc-
ture (Fig. 3, L and M). These results lead us to conclude that 
the loss of function of VRK3 results in a synaptic structural 
defect. The physiological characteristics are largely normal in 
VRK3-KO synapses, so we assume two reasons for this defect: 
(1) relatively weak changes in signaling factors that fail to 
produce profound functional changes, and (2) compensation 
mechanisms, possibly from changes in binding partners, an-
other subtype, or down-stream signal transduction. A clearer 
understanding of the physiological compensation mechanism 
observed in our VRK3-KO animals requires further study. 
Interestingly, VRK3-KO animals showed decreased rectifi-
cation of AMPA receptor–mediated postsynaptic currents, 
which is mediated by altered AMPA receptor composition 
and a decrease in GluA2-lacking Ca2+-permeable AMPA re-
ceptors (Anggono and Huganir, 2012). In fact, the modulation 
of Ca2+-permeable AMPA receptors caused by changes in 
AMPA receptor composition regulates neuronal function, and 
its perturbation causes neurological disease (Liu and Zukin, 
2007; Clem and Huganir, 2010; Whitehead et al., 2017). Thus, 
our results provide an important clue about the relationship 
between ASD-related behavior and Ca2+-permeable AMPA 
Figure 8. recovery of social interaction 
deficits by acute treatment with 7,8-dHF 
in VrK3-Ko mice. (A and B) Sociability and 
preference for social novelty at 1 d (test 1) 
after acute treatment with 7,8-DHF or vehi-
cle; sociability with mouse 1 (blank bar) ver-
sus object (filled bar; A: n = 7, 8 and 8, 9 for 
WT and VRK3-KO mice; WT vs. VRK3 KO F1,56 = 
49.99, P < 0.0001, interaction F3,56 = 3.61, P = 
0.0186, two-way ANO VA; ***, P < 0.001; **, P 
< 0.01; Bonferroni’s post-test) and preference 
for social novelty with familiar mouse (blank 
bar) versus novel mouse (filled bar; B: WT vs. 
VRK3 KO F1,56 = 22.17, P < 0.0001, interaction 
F3,56 = 4.58, P = 0.0069, two-way ANO VA; ***, 
P < 0.001; **, P < 0.01; *, P < 0.05; Bonferroni’s 
post-test). (C and D) Sociability and preference 
for social novelty at 7 d (test 2) after acute 
treatment with 7,8-DHF or vehicle, sociability 
(C: n = 7 and 8, 9 for WT and VRK3-KO mice; 
WT vs. VRK3 KO F1,42 = 10.01, P = 0.0029, inter-
action F2,42 = 4.55, P = 0.0163, two-way ANO 
VA; ***, P < 0.001, Bonferroni’s post-test), and 
preference for social novelty (D: WT vs. VRK3 
KO F1,42= 4.13, P = 0.0487, two-way ANO VA; 
*, P < 0.05, Bonferroni’s post-test). n.s., not 
significant. All values represent mean ± SEM.
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receptors, offering a motivation to monitor the changes in 
Ca2+-permeable AMPA receptors in other animal models 
of ASD-related behavior.
We previously studied the mechanisms of VRK3 ac-
tion and found that VRK3 is a negative modulator of ERK 
that affects many signaling pathways (Kang and Kim, 2006). 
Because ERK has various effects on synaptic proteins as well 
(Chao, 2003; Santos et al., 2010), the expression of signal-
ing molecules, scaffolding proteins, and receptors in relation 
to synaptic proteins are likely altered in VRK3-KO mice. In 
our results, ERK phosphorylation in VRK3-KO animals in-
creased in a much slower and delayed manner compared with 
WT animals, which showed much faster kinetics of ERK 
phosphorylation (Fig. 6 B). We hypothesized that this was be-
cause (1) the basal level of phosphorylated ERK was already 
increased in VRK3-KO mice, and (2) a lower level of TrkB 
expression in VRK3-KO mice caused slow additional activa-
tion of ERK. It has been suggested that TrkB signaling is also 
a critical pathway modulating changes in synaptic strength 
for cognitive processes such as memory formation (von 
Bohlen und Halbach et al., 2006; Minichiello, 2009; Fortin 
et al., 2012; Bennett and Lagopoulos, 2014). In our results, it 
is important to note that the difference between ERK phos-
phorylation in both WT and VRK3-KO mice was decreased 
when 7,8-DHF treatment was sustained (e.g., in 4–8 h), de-
spite the different time course/kinetics of the 7,8-DHF ef-
Figure 9. recovery of social interac-
tion deficits and stereotyped behaviors 
by chronic treatment with 7,8-dHF in 
VrK3-Ko mice. (A) Duration of groom-
ing behavior 1 wk (test 1) after final chronic 
treatment with 7,8-DHF or vehicle in WT and 
VRK3-KO mice (n = 5–7 for WT and VRK3-KO 
mice; ***, P < 0.001; **, P < 0.01; t test). (B and 
C) Sociability and preference for social novelty 
at 1 wk (test 1) after final chronic treatment 
with 7,8-DHF or vehicle, sociability with mouse 
1 (blank bar) versus object (filled bar; B: n = 6, 
7 and 6, 9 for WT and VRK3-KO mice; WT vs. 
VRK3 KO F1,48 = 31.50, P < 0.0001, interaction 
F3,48 = 7.17, P = 0.0005, two-way ANO VA; ***, 
P < 0.001; **, P < 0.01, Bonferroni’s post-test), 
and preference for social novelty with familiar 
mouse (blank bar) versus novel mouse (filled 
bar; C: n = 6, 7 and 6, 9 for WT and VRK3-KO 
mice; WT vs. VRK3 KO F1,48 = 25.13, P < 0.0001, 
two-way ANO VA; *, P < 0.05, Bonferroni’s 
post-test). (D and E) Sociability and preference 
for social novelty at 5 wk (test 2) after final 
chronic treatment with 7,8-DHF or vehicle, so-
ciability (D: n = 5 and 6, 8 for WT and VRK3-KO 
mice; WT vs. VRK3 KO F1,32= 16.84, P = 0.0003, 
two-way ANO VA; **, P < 0.01; Bonferroni’s 
post-test), and preference for social novelty (E: 
n = 5 and 6, 8 for WT and VRK3-KO mice; WT 
vs. VRK3 KO F1,32= 8.89, P = 0.0055, two-way 
ANO VA; *, P < 0.05, Bonferroni’s post-test). (F 
and G) Sociability and preference for social 
novelty at 13 wk (Test 3) after final chronic 
treatment with 7,8-DHF or vehicle; sociability 
(F: n = 5 and 6, 8 for WT and VRK3-KO mice; WT 
vs. VRK3 KO F1,32= 20.13, P < 0.0001, two-way 
ANO VA; **, P < 0.01; Bonferroni’s post-test), 
and preference for social novelty (G: n = 5 and 
6, 8 for WT and VRK3-KO mice; WT vs. VRK3 KO 
F1,32= 5.04, P = 0.0315, two-way ANO VA; *, P < 
0.05, Bonferroni’s post-test). n.s., not signifi-
cant. All values represent mean ± SEM.
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fect. The phenotypes in VRK3-KO mice are likely mediated 
by ERK, as VRK3 interacts with ERK and negatively mod-
ulates ERK phosphorylation. Therefore, we hypothesize that 
changes in signaling factors such as Arc, phosphorylated TrkB, 
PSD-95, phosphorylated mTOR, and phosphorylated S6K 
in VRK3-KO mice are caused by basally increased ERK ac-
tivation. We confirmed that the difference in these signaling 
factors between VRK3-KO and WT mice was also reduced 
when 7,8-DHF treatment was sustained. CaMKIIα is also a 
major variable in VRK3-KO mice and an important modu-
lator of synaptic structure and function. However, we found 
that 7,8-DHF failed to reverse the increase in phosphory-
lated CaMKIIα in the PSD fraction of VRK3-KO mice to 
WT levels, whereas reduced levels of PSD95 and phosphory-
lated TrkB were significantly restored by 7,8-DHF treatment 
(Fig.  7  A). These results lead us to confirm that 7,8-DHF 
treatment restores the structural and functional phenotypes in 
VRK3-KO mice via an ERK-dependent signaling pathway.
For an in-depth look at the etiological mechanisms 
of autism-like behavior in VRK3-KO mice, it is import-
ant to compare the characteristics of VRK3-KO mice with 
those of existing ASD animal models. Ube3a knockout is 
a well-known animal model of Angelman syndrome, and 
these mice exhibit autism-like behavior. Interestingly, some 
phenomena we observed in VRK3-KO mice are similar 
to those observed in Ube3A-KO animals (e.g., analogous 
up-regulation of CaMKIIα and Arc and down-regulation of 
PSD-95, mTOR, GluA1, and TrkB; Weeber et al., 2003; van 
Woerden et al., 2007; Cao et al., 2013; Ebert and Greenberg, 
2013). An increase in Arc levels in the Ube3a-KO mouse 
is a phenotype that also appears in the VRK3-KO mouse. 
However, Ube3a maternal-deficient mutant animals show 
a decreased LTP (Weeber et al., 2003), whereas VRK3-KO 
animals show an intact LTP. In addition, Ube3a-KO an-
imals have normal phosphorylated ERK levels, whereas 
VRK3-KO animals have increased phosphorylated ERK lev-
els (Cao et al., 2013). In fact, the various characteristics of the 
ASD animal models make it difficult to define the etiolog-
ical mechanism of ASD as a single factor/pathway. For ex-
ample, NMDA receptor activity, the most widely recognized 
ASD-related factor to date, varies widely among ASD animal 
models (Lee et al., 2015; Kim et al., 2017). Because ERK is 
one of the downstream signals of NMDA receptor signaling 
(Thomas and Huganir, 2004), it is also closely related to our 
VRK3-KO study. However, Ube3a-KO animals (Yashiro et 
al., 2009; Kaphzan et al., 2012) and our VRK3-KO animals 
(Fig. 4 G) commonly have a normal NMDA/AMPA ratio, 
whereas neurologin-1–KO animals (Blundell et al., 2010), 
Shank2-KO animals (Won et al., 2012), and Shank3-KO an-
imals (Peça et al., 2011) show reduced NMDA functioning, 
including a reduced NMDA/AMPA ratio. Even IRSp53-KO 
mice with autism-like behavior exhibit increased NMDA 
Figure 10. Acute and chronic trkB stim-
ulation have no effect on anxiety in 
VrK3-Ko mice. (A) Duration of time spent 
(left) and total locomotor activity (right) in the 
open arms of the elevated plus maze 1 d (test) 
after acute 7,8-DHF or vehicle treatment in WT 
and VRK3-KO mice (n = 6, 6 and 7, 10 for WT 
and VRK3-KO mice). (B) Locomotor activity in 
the center region of the open field as shown by 
time spent in the center 1 d (test) after acute 
7,8-DHF or vehicle treatment (n = 7, 8 and 8, 
10 for WT and VRK3-KO mice). Chronic treat-
ment with 7,8-DHF and test schemes. (C and 
D) Duration of time spent in the open arms of 
the elevated plus maze (C) and in the center 
region of the open field (D) at 1 wk (test 1) 
after final chronic treatment with 7,8-DHF or 
vehicle (n = 5–8 for WT and VRK3-KO mice). (E 
and F) Duration of time spent in the open arms 
of the elevated plus maze (E) and in the center 
region of the open field (F) at 13 wk (test 2) 
after chronic treatment with 7,8-DHF or vehi-
cle (n = 6–10 for WT and VRK3-KO mice). n.s., 
not significant. *, P < 0.05, two-tailed t test. All 
values represent mean ± SEM.
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functioning (Chung et al., 2015). These findings suggest that 
the etiology of ASD cannot be elucidated with a single causal 
factor. For that reason, it may be difficult to treat patients with 
mutations in Ube3a in the same way as patients with neurol-
igin-1 mutations, suggesting that appropriate treatment can 
be provided by accurately assessing the cause of ASD in in-
dividual patients. Therefore, we expect that efforts to identify 
and analyze ASD-related factors such as VRK3 will become 
increasingly important in the future.
Many studies have focused on applying exogenous 
BDNF to the brainstem preparation and found that it cor-
rected synaptic defects and neuronal dysfunction (Lu et al., 
2013). However, because of the difficulty in central ner-
vous system delivery and the poor bioavailability of BDNF, 
7,8-DHF, which imitates BDNF and acts as a robust TrkB ag-
onist, has been proposed as a potential therapeutic tool (Lu et 
al., 2013). Using a combination of in vivo and in vitro applica-
tion of 7,8-DHF, we have found that acute and chronic TrkB 
activation by 7,8-DHF has beneficial effects on autism-like 
behaviors of VRK3-KO mice. Intriguingly, the acute applica-
tion of 7,8-DHF in adult mice elicited a short-lasting effect, 
but long-term stimulation of TrkB by 7,8-DHF treatment in 
younger mice almost completely recovered the impairment of 
social interaction in VRK3-KO mice. In addition, long-term 
treatment with 7,8-DHF restored stereotyped behaviors and 
impaired learning and/or memory in VRK3-KO mice. It 
has been widely considered that developmental alterations 
of neuronal networks may be difficult to restore by pharma-
cological intervention after the expected onset of symptoms. 
Therefore, our results demonstrate that long-term stimulation 
of TrkB before the onset of ASD symptoms is an effective 
strategy for the treatment of neurodevelopmental disorders. 
Finally, 7,8-DHF treatment failed to significantly affect anx-
iety in VRK3-KO mice (Fig. 10). The hypothesis that ASD 
and anxiety are consistently correlated is somewhat contro-
versial, although it is generally assumed that ASD is linked 
to increased anxiety. For example, like VRK3-KO mice, 
MeCP2-KO and Cdkl5-KO mice exhibit reduced anxiety 
with autism-like behavior (Pelka et al., 2006; Chahrour and 
Zoghbi, 2007; Wang et al., 2012). Our results suggest that 
autism-like behavior and anxiolytic behavior in VRK3-KO 
mice occur through different mechanisms.
Collectively, the key finding of the current study is that 
VRK3 deletion can cause down-regulation of TrkB and evoke 
abnormal spine and PSD structure and synaptic dysfunction, 
which lead to cognitive impairment and ASD-related behav-
iors that are caused by chromosomal abnormalities. We have 
also found that chronic TrkB activation by 7,8-DHF treat-
ment rescues impaired social interaction and learning/mem-
ory in VRK3-KO mice, which supports the hypothesis that 
TrkB stimulation could ameliorate autism-like behavior in 
VRK3-deficient mice. Our work is the first to validate that 
reduced VRK3 expression affects synaptic and cognitive func-
tion and suggests that TrkB stimulation is a possible pharmaco-
therapeutic strategy for the treatment of VRK3-related ASD.
MAterIAlS And MetHodS
Generation of VrK3-Ko mice
The gene-trapped embryonic stem cell line YTA189 (http 
://www .informatics .jax .org /allele /MGI :3880442) was 
obtained from BayGenomics (Stryke et al., 2003). This 
cell line was generated using a gene trap protocol with the 
pGT0Lxf construct, which contains the intron from engrailed 
2 upstream of a gene encoding β-galactosidase/neomycin 
resistance, β-geo (http ://www .genetrap .org). The embryonic 
stem cell clone was injected into a C57BL/6 blastocyst 
according to standard procedures (Stryke et al., 2003; Bult 
et al., 2010). Male chimeras were bred with C57BL/6 mice 
to create animals with a germline transmission of the mutant 
allele. Heterozygous mice were backcrossed with C57BL/6 
mice for a minimum of six generations before the study. 
Genotyping was performed by PCR and Southern blot using 
DNA extracted from mouse tails. Insertion of the neomycin 
phosphotransferase cassette was verified by PCR (neomycin 
primer: sense, 5′-GTT CTT TTT GTC AAG ACC GAC CT-3′; 
antisense, 5′-CTC TTC AGC AAT ATC ACG GGT AG-3′; Int7 
primer: sense, 5′-TTT ATG AAG TGA CCA AAG ACC TGA-
3′; antisense, 5′-GGG CTA GCA TCT CAA CTA CTA CCT-3′).
Quantitative real-time rt-Pcr
Total cerebral RNA was isolated and purified with TRI re-
agent (Molecular Research Center) from 12-wk-old WT or 
VRK3-KO littermate mice. Isolated RNA was reverse tran-
scribed using the ImProm-IITM Reverse Transcription Sys-
tem (Promega) according to the manufacturer’s instructions. 
For detection and quantification, the StepOnePlus Real-Time 
PCR System (Applied Biosystems) was used. The sequences 
of the forward and reverse primers were as follows: mouse 
VRK3, 5′-TGG GCT ATG GCT TCA CCT AC-3′ and 5′-
GGA CCC ATA AAG CCA CTT GA-3′; mouse ribosomal pro-
tein L32 (Rpl32), 5′-AAC CCA GAG GCA TTG ACA AC-3′ 
and 5′-CAC CTC CAG CTC CTT GAC AT-3′.
Behavioral analysis
All procedures for animal experiments were performed in ac-
cordance with Pohang University of Science and Technology 
guidelines on animal care and use and were approved by Pohang 
University of Science and Technology Institutional Animal Care 
and Use Committee (approval no. 2013–03-003-R1). Mice 
were fed ad libitum, and two to four animals were housed in a 
cage under a 12-h light cycle. Male mice were used for behav-
ioral experiments and nonbehavioral experiments, which mainly 
were performed with age-matched littermate pairs of male mice 
younger than 4 wk. All behavioral tests were conducted and 
analyzed by an experimenter blind to the genotype of the mice. 
All behavioral assessments were conducted when mice were 
12–15 wk old. All experiments were conducted during the light 
cycle and included littermate controls. Mice that showed poor 
health (e.g., skin lesions and slowed movement) or failed behav-
ioral experiments (e.g., a fall from the platform of the Barnes 
circular maze) were excluded from behavioral testing.
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Passive avoidance
Long-term memory was assessed with a step-through pas-
sive avoidance box (LET ICA LE 872; Bioseb) divided into 
a wide, white, illuminated compartment (250 W × 250 D × 
240 H cm3) and a small, black, dark compartment (195 W × 
108 D × 120 H cm3). Mice were detected by a weight sen-
sor under the floor covering both compartments. The grid 
of the dark compartment was designed to deliver an elec-
tric foot shock. For acquisition and conditioning, a mouse 
was placed in the illuminated compartment and allowed to 
freely explore the compartment until entering dark com-
partment. Each trial occurred as follows: the mouse was 
placed in the illuminated compartment at the furthest place 
from the closed door. After 10 s, the door opened. As soon as 
the mouse entered the dark compartment (the step-through 
maximum latency was fixed at 50 s, and all mice entered the 
dark compartment), the door was closed, and after 2 min, 
the mouse received a single inescapable electric shock (0.3 
mA, 1  s). The mouse then remained in the dark chamber 
for an additional 20  s before being removed and returned 
to its home cage. Two days later, the mouse was tested for 
memory retention. The mouse was returned to the white 
compartment (closed door for 10 s), and the latency to enter 
the dark compartment was recorded. The maximum step-
through latency was 600  s, and this value was recorded if 
the mouse did not enter the dark compartment. No electric 
shock was given during this session. All data are shown as 
mean ± SEM and analyzed using two-way ANO VA with 
Bonferroni’s post hoc analysis.
novel object recognition
The novel object recognition test was performed in an 
open field apparatus. During the habituation phase, a mouse 
was placed in the open field arena and allowed to explore 
for 10 min of habituation without any objects for 3 d. 
After habituation, two objects of similar size, shape, and 
color were placed in opposite corners of the arena, 10 cm 
from the side walls, and the mouse was placed in the cen-
ter of the arena and allowed to explore the arena and two 
objects for 10 min. After 24 h, during the test phase, one 
object was replaced with a novel object that was of sim-
ilar size but different shape and color. Then, the mouse 
was placed in the center and allowed to explore the arena 
and the two objects. Mouse movements were tracked and 
recorded by real-time video-tracking computer software 
Smart Version 2.5 (Panlab) linked to an overhead video 
camera. The time spent in each chamber and exploratory 
activity around the objects (2.5-cm zone around the ob-
jects) was recorded by real-time video-tracking computer 
software Smart Version 3.0 (Panlab) and video recording 
system (DT acquire software/Ancamcorder 3.3.4; Antools) 
and analyzed by two human observers blinded to genotype 
and not related to this experiment. All data are shown as 
mean ± SEM and analyzed using two-way ANO VA with 
Bonferroni’s post hoc analysis.
Barnes circular maze
The test was performed as described previously (Han et al., 
2012), with minor modifications. The Barnes circular maze 
consisted of a circular planar white Plexiglas platform (92-cm 
diameter) elevated 1 m from the floor with 20 evenly spaced 
holes (7-cm diameter) located 5 cm from the perimeter. A 
black escape box (15 × 7 × 7 cm) was placed under one hole. 
Spatial cues with distinct patterns and shapes were placed 
on the wall of the testing room. A 500-lux light was turned 
on during the trial. An experimenter was positioned in the 
same place with minimal movements throughout the trials. 
The platform and escape box were cleaned thoroughly with 
70% ethanol and paper towels between each trial to remove 
olfactory cues. 1 d before the training trials began, test mice 
were habituated in the target box for 3 min. The training trials 
were repeated for four consecutive days, and three trials were 
performed each day with 20-min intertrial intervals. At the 
beginning of each trial, a mouse was placed in the cylindrical 
holding chamber (10-cm diameter) located in the center of 
the maze. After 10 s of holding time, the mouse was allowed 
to search for the target hole for 3 min. If the mouse failed to 
find the target hole in 3 min, it was gently guided into the 
target hole by the experimenter’s hands. When the mouse en-
tered the escape box, the light was turned off, and the mouse 
remained undisturbed for 1 min. During training, the move-
ment of the mouse was recorded and the number of errors 
and latency to find the target hole was measured by real-time 
video-tracking computer software Smart Version 2.5 linked 
to an overhead video camera. On days 5 and 12, a probe 
trial was performed. The escape box was removed during the 
probe trials, and the mouse was allowed 90 s to find the target 
hole. During the probe trial, total distance moved and latency 
to find the target hole were measured. The percentages of 
correct pokes and time in the target area were also analyzed 
by real-time video-tracking computer software (Smart Ver-
sion 2.5). All data are shown as mean ± SEM and analyzed 
using two-way ANO VA with Bonferroni’s post-hoc analysis.
Stereotyped behavior
The time mice spent grooming during a 10-min open field 
test period was measured. Grooming behavior was defined 
as scratching or stroking of the face, head, or body with the 
two forelimbs or licking body parts. The observer was blind 
to mouse genotype. All data are shown as mean ± SEM and 
analyzed using Student’s two-tailed, unpaired t tests.
three-chamber test
The test was performed as described previously (Nadler et 
al., 2004; Silverman et al., 2010), with minor modifications. 
The three-chamber apparatus was a transparent Plexiglas box 
(60 W × 45 D × 40 H cm3) with two transparent partitions 
dividing left, center, and right chambers (20 × 45 cm). Each 
partition had a square opening (10 × 10 cm) in the bottom 
center. A cylindrical wire cage (8.5-cm diameter) was used 
as an inanimate object. A cylindrical bottle filled with water 
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was placed on the top of the wire cup to prevent the mouse 
from climbing to the top of the cup. The three-chamber unit 
and wire cups were cleaned with 70% ethanol and wiped 
with paper towels between each trial. The three-chamber test 
consisted of three phases. In the first phase, for habituation, 
a test mouse was placed in the center of the three-cham-
ber unit and allowed to explore the environment for 10 min. 
After habituation, an age- and gender-matched same strain 
mouse that had never been exposed to the test mouse (M1) 
was placed in one of the two wire cages. The empty wire cage 
as an inanimate object (O) cue was placed on the other side. 
Then, the test mouse was placed in the center and allowed 
to freely explore the chamber for 10 min. In the third phase, 
a second age- and gender-matched C57BL/6J mouse (M2) 
that had never been exposed to the test mouse was placed in 
the previously empty wire cage. Thus, the test mouse would 
have the choice between a mouse that was already familiar 
(M1) and a novel mouse (M2). The test mouse was placed in 
the center and allowed to freely explore the chamber for 10 
min. Exploration was defined as each instance in which the 
test mouse sniffed the empty cage/mouse or oriented its nose 
toward and came close to the object/stranger. The movement 
of the mouse was tracked and recorded by real-time vid-
eo-tracking computer software (Smart Version 2.5) linked to 
an overhead video camera. Time spent in each chamber and 
in a circular area (5-cm radius) around each wire cage was an-
alyzed by real-time video-tracking computer software (Smart 
Version 2.5). All data are shown as mean ± SEM and analyzed 
using two-way ANO VA with Bonferroni’s post hoc analysis.
Pup retrieval
Virgin female mice were isolated for 4 d before the pup re-
trieval test. Three pups (1–3 days old; C57BL/6) were placed 
in three different corners of the home cage of the mouse. 
Mice were allowed to retrieve the pups for 10 min. If mice 
did not complete retrieval within 10 min, the test was ter-
minated. The movement of mice was observed via an over-
head video camera linked to a monitor with Smart Version 
2.5. The latencies of pup retrieval were recorded. All data are 
shown as mean ± SEM and analyzed using two-tailed, un-
paired Student’s t tests or two-way ANO VA with Bonfer-
roni’s post hoc analysis.
nesting behavior
Isolated mice were given nest-building material, a white 
folded Kimwipe, in the center of their home cages. After 1, 2, 
and 3 d, the nesting material was photographed. Nesting was 
scored on a scale of 0 to 3 based on the extent to which the 
nesting material was converted into fine pieces. All data are 
shown as mean ± SEM and analyzed using two-way ANO VA 
with Bonferroni’s post hoc analysis.
open field test
Spontaneous exploratory activity and anxiety-like behavior 
were assessed in an automated open field. The open field test 
was performed as previously described (Chao et al., 2010). In 
brief, mice were placed in a wooden box (60 W × 40 D × 
20 H cm3), and mouse movements were recorded and ana-
lyzed by real-time video-tracking computer software (Smart 
Version 2.5) linked to an overhead video camera. The total 
distance traveled and time spent in the center (20 × 20–cm 
imaginary square) were measured for 10 min. The open field 
arena was cleaned with 70% ethanol and wiped with paper 
towels after each trial. All data are shown as mean ± SEM and 
analyzed using two-tailed, unpaired Student’s t tests.
ePM
The EPM apparatus was a plus-shaped maze elevated 60 cm 
above the floor. It consisted of two closed arms surrounded 
by 30-cm-high opaque walls and two open arms (110 × 110 
cm). Each mouse was placed in the center (5 × 5 cm) of the 
maze facing one of the closed arms and allowed to explore 
the space for 15 min. The movement of mice was tracked 
and recorded via an overhead video camera and further ana-
lyzed by real-time video-tracking computer software (Smart 
Version 2.5). Time spent in the closed arms, center, and open 
arms was measured. The maze was cleaned with 70% ethanol 
and wiped with paper towels between each trial. All data are 
shown as mean ± SEM and analyzed using two-tailed, un-
paired Student’s t tests.
light–dark exploration
The light–dark test is based on the natural conflict of mice 
between an innate aversion to brightly illuminated areas and 
the desire to explore a novel environment. The apparatus 
consisted of a light compartment made of white plastic (20 
× 20 × 20 cm3) and a dark compartment made of black plas-
tic (20 × 20 × 20 cm3). The light and dark compartments 
were separated by a partition with a tunnel (13× 7.5 × 13.5 
cm3) to allow passage from one compartment to the other. 
The light compartment was brightly illuminated with a light 
intensity of 400 lux, and the dark compartment was black-
walled and covered at the top with black Plexiglas. At the 
beginning of the test, a mouse was placed in the center of 
the light compartment facing the tunnel, and the door of the 
tunnel opened 3 s later. The mouse was then allowed to freely 
explore the entire apparatus for 10 min. The movement of 
mice was tracked and recorded by real-time video-tracking 
computer software (Smart Version 2.5) linked to an overhead 
video camera. The total duration in the light box was mea-
sured. The apparatus was thoroughly cleaned with 70% eth-
anol after each trial. All data are shown as mean ± SEM and 
analyzed using two-tailed, unpaired Student’s t tests.
Golgi–cox staining
At 13 wk of age, 16 mice (n = 8 per group) were perfused first 
with phosphate-buffered saline and then with 4% parafor-
maldehyde. For Golgi staining, we used the FD Rapid Golgi 
staining kit (FD Neuro Technologies) following the manu-
facturer’s protocol. Coronal brain slices were prepared with 
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a vibratome (Leica) at a thickness of 100 µm and mounted 
on gelatin-coated microscope slides. Images of dorsal hippo-
campal regions were taken with an Olympus Fluoview 1000 
confocal microscope and analyzed in a blinded manner using 
ImageJ (National Institutes of Health). At least three neurons 
per animal (pyramidal neurons in the CA1 region and granule 
cells in the DG) were selected for quantification. Spine length 
and density were analyzed in >10-µm segments of secondary 
and third apical dendrite images or primary and secondary 
basal dendrite images obtained from each dendrite image 
within a single focal plane at 63× magnification. For apical 
dendrites, 10-µm segments 100–150 µm from the cell soma 
were randomly selected and assessed. For basal dendrites, 
spines were also scored along 10-µm segments located 50 to 
100 µm from the soma. The types of spines were divided into 
four categories (thin, mushroom, stubby, and branched) based 
on the approximate measurements according to previously 
described criteria (Harris et al., 1992). In brief, types of spines 
were defined as follows: thin (the length was greater than 
the neck diameter, and the diameters of the head and neck 
were similar), mushroom (diameter of the head was much 
greater than the diameter of the neck), stubby (the diameter 
of the neck was similar to the total length of the spine), and 
branched (it has more than one head). The dendritic branch-
ing patterns were analyzed using Sholl’s method (Sholl, 1953). 
40× magnification images (Z-stack with 1-µm intervals) of 
pyramidal neurons in dorsal CA1 were captured, and each 
neuron was reconstructed using Adobe Photoshop CS6 and 
Image J (National Institutes of Health). Images were sub-
jected to Sholl analysis using Image J (National Institutes of 
Health) with a starting radius of 10 µm and radius increments 
of 10 µm ending at 140 µm.
PSds
200-µm brain sections containing the hippocampal CA1 re-
gion were prepared from 12-wk-old WT and VRK3-KO 
mice and fixed with 2% paraformaldehyde and 2% glutaral-
dehyde containing 0.05 M sodium cacodylate buffer, pH 7.2, 
at 4°C for 4 h. Prefixed samples were washed with 0.05 M 
sodium cacodylate buffer, pH 7.2, and postfixed with 1% os-
mium tetroxide at 4°C for 2 h. After washing briefly with dis-
tilled water, the fixed samples were treated with 0.5% uranyl 
acetate at 4°C for 30 min, exchanged in graded ethanol, and 
infiltrated with a graded series of propylene oxide and Spurr’s 
resin mixtures. Infiltrated samples were polymerized at 70°C 
for 24  h. Ultrasections were obtained using an ultramicro-
tome (MT-X, RMC) and stained with 2% uranyl acetate and 
Reynolds’ lead citrate. Images were obtained using a JEM-
1011 electron microscope (JEOL).
PSd fractionation
The PSD fractionation procedure was performed as described 
previously (Bermejo et al., 2014), with minor modifica-
tions. In brief, tissue from mouse brain was homogenized in 
Hepes-buffered sucrose (320 mM sucrose and 5 mM Hepes, 
pH 7.4) containing protease inhibitor mixture (Roche) 
using a Teflon douncer. The homogenate was centrifuged at 
1,000 g for 15 min at 4°C to remove cell debris and nuclei. 
The supernatant was spun for 20 min at 25,000 g to obtain 
the soluble and crude synaptosomal fraction. This fraction was 
resuspended in Hepes-buffered sucrose solution and fraction-
ated by sucrose density-gradient centrifugation (0.8/1.0/1.2 
sucrose) at 200,000 g for 2 h at 4°C. Purified synaptosomes/
synaptic plasma membranes were collected at the 1.0–1.2-M 
interface. To obtain the one-triton–extracted PSD fraction, 
synaptosomes were resuspended in 5 vol 1 mM Tris, pH 8.1, 
rotated for 15 min at 4°C in buffer containing 0.5% Triton 
X-100/Hepes/EDTA solution, and centrifuged at 33,000 g 
for 30 min. The resulting pellet was resuspended in 50 mM 
Hepes/2 mM EDTA solution and stored at −80°C until it 
was used for Western blotting.
Immunoblotting
Hippocampi were homogenized in 1 × cell lysis buffer 
(20 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 
1% Triton-X 100, 2.5  mM sodium pyrophosphate, 1  mM 
β-glycerophosphate, 1 mM Na3VO4, 10% glycerol, 1 µg/ml 
leupeptin), and samples were sonicated and centrifuged at 
15,000 rpm for 30 min at 4°C. The supernatant was removed, 
and the protein concentration was determined using Brad-
ford reagent (Amresco). Samples were denatured for 5 min 
at 95°C with SDS sample buffer containing β-mercaptoeth-
anol. Proteins were separated by SDS-PAGE and transferred 
to nitrocellulose membranes and proved with the indicated 
antibodies. The immunoblots were quantified using ImageJ 
software. VRK3 antiserum was generated according to an es-
tablished protocol (Kang and Kim, 2006; WB 1:100). Other 
antibodies specific for β-galactosidase (Z378A, WB 1:1,000; 
Promega), CaMKII (M-176; 9035, WB 1:1,000; Santa Cruz 
Biotechnology), pCaMKII (Thr286; 12886, WB 1:1,000; Santa 
Cruz Biotechnology), p44/42 MAPK (Erk1/2; 9102, WB 
1:1,000; Cell Signaling), phospho-p44/42 MAPK (Erk1/2; 
Thr202/Tyr204; 4695, WB 1:1,000; Cell Signaling), mTOR 
(2972, WB 1:1,000; Cell Signaling), phospho-mTOR (S2448; 
2971, WB 1:1,000; Cell Signaling), phospho-p70 S6 kinase 
(Thr421/Ser424; 9204, WB 1:1,000; Cell Signaling), p70 S6 
kinase (9202, WB 1:1,000; Cell Signaling), 14-3-3ζ (1019, 
WB 1:1,000; Santa Cruz Biotechnology), α-tubulin (5286, 
WB 1:1,000; Santa Cruz Biotechnology), syntaxin (7562, WB 
1:1,000; Santa Cruz Biotechnology), Arc (SYSY 156 003, 
WB 1:1,000; Synaptic Systems), SynGAP (R-19; 8572, WB 
1:1,000; Santa Cruz Biotechnology), Homer1 (ABN37, WB 
1:1,000; Millipore), PAK3 (2609, WB 1:1,000; Cell Signaling), 
SAP97 (2D11; 9961, WB 1:1,000; Santa Cruz Biotechnol-
ogy), PSD-95 (18258, WB 1:1,000; Abcam), GluR1 (82211, 
WB 1:1,000; Abcam), GluN1 (PA3-102, WB 1:1,000; Thermo 
Fisher Scientific), GluN2A (1468, WB 1:1,000; Santa Cruz 
Biotechnology), GluN2B (1469, WB 1:1,000; Santa Cruz Bio-
technology), GluA1 (182 003, WB 1:1,000; Synaptic Systems), 
GluA2 (AB1768, WB 1:1,000; Millipore), GluA3 (MAB5416, 
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WB 1:1,000; Millipore), TrkB (80E3; 4603, WB 1:1,000; Cell 
Signaling), and pTrkB (Tyr 706; 135645, WB 1:1,000; Santa 
Cruz Biotechnology) were used.
Hippocampal slice preparation
Transverse hippocampal slices (300 µm for whole-cell patch-
clamp recordings and 400 µm for extracellular field potential 
recordings) were prepared from 3–4-wk-old and 6–7-wk-old 
(rectification experiment) WT or VRK3-KO littermate mice 
(male only) as described previously (Seo et al., 2012; Choi 
et al., 2015). In brief, brains were isolated rapidly and placed 
in ice-cold, oxygenated (95% O2 and 5% CO2) low-Ca2+/
high-Mg2+ dissection buffer containing 5 mM KCl, 1.23 mM 
NaH2PO4, 26  mM NaHCO3, 10  mM dextrose, 0.5  mM 
CaCl2, 10 mM MgCl2, and 212.7 mM sucrose. Slices were 
incubated in oxygenated (95% O2 and 5% CO2) artificial ce-
rebrospinal fluid (ACSF) containing 124 mM NaCl, 5 mM 
KCl, 1.23 mM NaH2PO4, 2.5 mM CaCl2, 1.5 mM MgCl2, 
26 mM NaHCO3, and 10 mM dextrose at 28–30°C for at 
least 1 h before recording.
extracellular field potential recordings
After recovery, slices were transferred to a recording cham-
ber, where they were perfused continuously with oxygen-
ated ACSF (27–28°C) at a flow rate of 2 ml/min. fEPSPs in 
the CA1 area were elicited by hippocampal SC stimulation 
(0.2-ms current pulses) using a concentric bipolar electrode. 
Synaptic responses recorded by ACSF-filled microelectrodes 
(1–3 MΩ) were quantified by the initial slope of the fEPSP. 
Recordings were performed using an AM-1800 microelec-
trode amplifier (A-M Systems), PG 4000A stimulator (Cyg-
nus Technology), and SIU-90 isolated current source (Cygnus 
Technology). Baseline responses were collected at 0.07 Hz 
with a stimulation intensity that yielded a 40–60% maximal 
response. NMDA receptor–dependent LTP was induced by 
four episodes of theta-burst stimulation at 10-s intervals. The-
ta-burst stimulation consisted of 10 stimulus trains delivered 
at 5 Hz; each train consisted of four pulses at 100 Hz. NMDA 
receptor–dependent LTD was induced by single-pulse 
low-frequency stimulation consisting of 900 pulses at 1 Hz 
for 900  s. Group I mGluR-dependent LTD was induced 
by a 10-min bath application of 100 µM (R,S)-3,5-DHPG 
(Tocris Bioscience). Data from slices with stable recordings 
(<5% change over the baseline period) were included in the 
analysis. All data are presented as mean ± SEM normalized 
to the preconditioning baseline (at least 20 min of stable re-
sponses). The experimenters were blind to mouse genotype. 
IGOR software (Wavemetrics) was used for digitizing and 
analyzing the responses.
Whole-cell patch-clamp recordings
Slices were transferred to a recording chamber, where they 
were perfused continuously with oxygenated ACSF (23–
25°C) at a flow rate of 2 ml/min. Slices were equilibrated 
for 5 min before recordings. All recordings were performed 
in hippocampal CA1 pyramidal neurons, which were iden-
tified by their size and morphology. Patch pipettes (4–6 
MΩ) were filled with 130 mM Cs-MeSO4, 0.5 mM EGTA, 
5 mM TEA-Cl, 8 mM NaCl, 10 mM Hepes, 1 mM QX-314, 
4  mM ATP-Mg, 0.4  mM GTP-Na, 10  mM phosphocre-
atine-Na2, and 0.1 mM Spermine (for the mEPSC, sEPSC, 
and evoked EPSC experiments), 130  mM CsCl, 1.1  mM 
EGTA, 2 mM MgCl2, 0.1 mM CaCl2, 10 mM NaCl, 10 mM 
Hepes, 2 mM ATP-Na (for mIPSC and sIPSC experiments), 
145 mM K-gluconate, 5 NaCl, 10 mM Hepes, 0.2 EGTA, 
1 MgCl2, 2 ATP-Mg, and 0.1 GTP-Na (for excitability ex-
periments) at a pH of 7.4 and 280–290 mOsm. The extra-
cellular recording solution consisted of ACSF supplemented 
with 100 µM picrotoxin, 1 µM TTX, and 50 µM DL-AP5 
for mEPSC experiments; 100 µM picrotoxin for the sEPSC 
and evoked EPSC experiment; 1 µM TTX, 20 µM CNQX, 
and 50 µM DL-AP5 for the mIPSC experiment; and 20 µM 
CNQX and 50  µM DL-AP5 for the sIPSC experiment. 
Neuronal excitability was measured by injecting step depo-
larizing currents for 500 ms. All evoked EPSCs were elicited 
by SC stimulation (0.1-ms current pulses) at 0.07 Hz using 
a concentric bipolar electrode placed 200–300 µm in front 
of postsynaptic pyramidal cells, and these experiments were 
conducted in external solution containing elevated divalent 
cations (4 mM Ca2+ and Mg2+) to reduce network excitability 
and prevent polysynaptic responses upon stimulation (Clem 
and Huganir, 2010). For the experiments testing paired-pulse 
responses, the AMPA/NMDA ratio, and the current–voltage 
relationship of AMPA receptors, we evoked EPSCs by ap-
plying stimulations at half-maximal intensity (80–100 pA). 
The paired-pulse responses were obtained by two closely 
separated stimulations at 50-ms interstimulus intervals. The 
paired pulse ratio was depicted by the amplitude ratio of sec-
ond EPSP/first EPSP. For AMPA/NMDA ratio experiments, 
CA1 pyramidal neurons were initially held at −70 mV, and 10 
AMPA receptor–mediated EPSCs were evoked. After record-
ing AMPA receptor–mediated EPSCs, 20  µM CNQX was 
added to the ACSF, and the holding potential was changed to 
+40 mV to record NMDA receptor–mediated EPSCs. The 
AMPA/NMDA ratio was calculated by dividing the mean 
value of 10 AMPA receptor–mediated EPSC peak amplitudes 
by the mean value of 10 NMDA receptor-mediated EPSC 
peak amplitudes. To verify the current-voltage relationship of 
AMPA receptors in hippocampal SC-CA1 synapses in WT or 
VRK3-KO mice, recordings were made with 50 µM of the 
NMDA receptor antagonist DL-AP5 in the external solution. 
EPSCs were evoked at multiple holding potentials (−70, −60, 
−40, −20, 0, +20, and +40 mV). Data were acquired using 
an EPC-8 amplifier (HEKA) or Multiclamp 700B amplifier 
(Molecular Devices), filtered at 2 kHz and digitized at 10 kHz 
with Digidata 1440A or 1550B1 (Molecular Devices), and 
analyzed using pClamp 10.2 (Molecular Devices). Only cells 
with access resistance <20 MΩ and input resistance >100 
MΩ were studied. Cells were discarded if the input or access 
resistance changed by more than 20%.
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Pharmacological treatment
7,8-DHF was purchased from Sigma (D5446), dissolved in 
phosphate-buffered saline containing 17% DMSO to a final 
concentration of 10 mg/kg, and administered by intraper-
itoneal injection at a volume of 0.01  ml/g. For transient 
treatment, 7,8-DHF was administered to 12-wk-old mice 
once daily for three consecutive days, and mice were sub-
jected to behavioral tests 1 and 7 d after treatment (Fig. 8 
and Fig. 10, A and B). For chronic treatment, 7,8-DHF was 
administered to 4-wk-old mice at 1-wk intervals until mice 
reached 11 wk of age, and behavioral tests were performed 
at 12, 16, and 24 wk of age (Fig. 9 and Fig. 10, C–F). For 
electrophysiological experiments, 7,8-DHF was suspended 
to a 10 mM concentration in DMSO and diluted 1:1,000 
in external solution; therefore, final concentration to 
treat 7,8-DHF is 10  µM with 0.1% DMSO. Vehicle solu-
tion was composed of same one described previously but 
excluding 10 µM 7,8-DHF.
Statistical analysis
All data are shown as mean ± SEM and analyzed using χ2 
tests, unpaired two-sided Student’s t tests, one-way ANO 
VA with Turkey’s post-hoc tests, or two-way ANO VA with 
Bonferroni’s post-hoc tests. For Sholl analysis of dendritic 
complexity, we used a repeated-measures two-way ANO 
VA with genotype and radius as factors. All statistical anal-
yses were performed using Prism 4 (GraphPad), Micro-
soft Office (for graphical display, version 15.0.4569.1506; 
Microsoft), or SigmaPlot (for statistical analysis, version 
11.0; Systat Software).
online supplemental material
Fig. S1 shows the gene trap insertion site and the effect on 
VRK3 protein. Fig. S2 shows that VRK3 mutant mice ex-
hibit impaired learning and memory performance along with 
hyperactivity and anxiolytic behavior. Fig. S3 shows the nor-
mal basal synaptic transmission and metabotropic glutamate 
receptor-induced LTD in VRK3-KO mice. Fig. S4 shows the 
biochemical changes in the hippocampal PSD fraction and 
whole lysates of young VRK3-KO mice. Fig. S5 shows the 
restorative effects of 7,8-DHF on the deficits in learning and 
memory in VRK3-KO mice.
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